Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT04683146 |
Other study ID # |
RICBEC2 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
Phase 4
|
First received |
|
Last updated |
|
Start date |
March 10, 2021 |
Est. completion date |
June 5, 2021 |
Study information
Verified date |
December 2020 |
Source |
Centro Ortopedico y Quirurgico del Pie |
Contact |
Ricardo Becerro de Bengoa Vallejo |
Phone |
+34 670678145 |
Email |
ribebeva[@]ucm.es |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The present study evaluates the effects of bactericidal load reduction after surgical hand
antisepsis using the reference antiseptic product propanol- 1 60% as control versus a
surgical hand antisepsis with addition of a solution of alcohol, chlorhexidine digluconate
and potassium sorbate in order to test if pass the standard european norm 12791.
Description:
The investigators conducted a crossover clinical trial to evaluate the antiseptic
effectiveness of surgical hand antisepsis using propan-ol-1 60% by using the reference
antiseptic product propan-ol-1 60% as control versus a surgical hand antisepsis with addition
of a solution of alcohol, chlorhexidine digluconate and potassium sorbate in order to test if
pass the standard european norm 12791. Samples will be taken from the hands of each volunteer
after a surgical hands antiseptic.